2007
DOI: 10.1016/j.biomaterials.2007.05.020
|View full text |Cite
|
Sign up to set email alerts
|

Identification and characterization of bioactive factors in bladder submucosa matrix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
105
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 169 publications
(108 citation statements)
references
References 33 publications
1
105
0
Order By: Relevance
“…Additionally, the extent to which matricryptic peptides remain active in vivo is not known. Because ECM scaffolds consist of various molecules such as collagen and fibronectin, proteoglycans, glycoproteins, growth factors, and cytokines (46), degradation of these ECM scaffolds releases a heterogeneous set of molecules (13,21), each with varying biologic properties in vivo. Subsets of these peptides have been found to have different bioactive properties in vitro (13,17,19,44,47,48).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the extent to which matricryptic peptides remain active in vivo is not known. Because ECM scaffolds consist of various molecules such as collagen and fibronectin, proteoglycans, glycoproteins, growth factors, and cytokines (46), degradation of these ECM scaffolds releases a heterogeneous set of molecules (13,21), each with varying biologic properties in vivo. Subsets of these peptides have been found to have different bioactive properties in vitro (13,17,19,44,47,48).…”
Section: Discussionmentioning
confidence: 99%
“…Although the mechanisms by which these materials support and promote a constructive remodeling process are only partially understood, it appears clear that rapid degradation of the scaffold material with concurrent release of both intact growth factors and newly generated bioactive matricryptic peptides as well as the provision of unique surface architectures are factors that play an important role. [34][35][36][37][38][39][40][41] The ability to promote constructive remodeling in vivo has also been shown to be highly dependent on the methods used in preparing the scaffold material. 19,20,42 For example, chemical crosslinking is often used to increase the mechanical strength of a scaffold material, to slow degradation, or to mask cellular epitope that may remain within the scaffold material after decellularization.…”
Section: Figmentioning
confidence: 99%
“…Both materials have been shown to be biocompatible and safely used clinically (11,12,34,35). Acellular tissue matrix, obtained from porcine bladders, was processed using a multiple-step detergent wash protocol developed in our laboratory (12,16) …”
Section: Preparation Of Composite Biomaterialsmentioning
confidence: 99%
“…Each type of biomaterials has desirable traits which are exclusive of the other. Acellular tissue matrices possess the desired biocompatibility (11)(12)(13), contain biomimetic factors (14)(15)(16)) that promote tissue development and have adhesion domain sequences (e.g., RGD) that may assist in retaining the phenotype and activity of many types of cells (17). These matrices are known to slowly degrade upon implantation and are usually replaced and remodeled by ECM proteins synthesized and secreted by transplanted or ingrowing cells (18)(19)(20)(21)(22)(23)(24)(25).…”
Section: Introductionmentioning
confidence: 99%